210 related articles for article (PubMed ID: 19458360)
1. Metnase mediates chromosome decatenation in acute leukemia cells.
Wray J; Williamson EA; Sheema S; Lee SH; Libby E; Willman CL; Nickoloff JA; Hromas R
Blood; 2009 Aug; 114(9):1852-8. PubMed ID: 19458360
[TBL] [Abstract][Full Text] [Related]
2. Metnase mediates resistance to topoisomerase II inhibitors in breast cancer cells.
Wray J; Williamson EA; Royce M; Shaheen M; Beck BD; Lee SH; Nickoloff JA; Hromas R
PLoS One; 2009; 4(4):e5323. PubMed ID: 19390626
[TBL] [Abstract][Full Text] [Related]
3. The SET and transposase domain protein Metnase enhances chromosome decatenation: regulation by automethylation.
Williamson EA; Rasila KK; Corwin LK; Wray J; Beck BD; Severns V; Mobarak C; Lee SH; Nickoloff JA; Hromas R
Nucleic Acids Res; 2008 Oct; 36(18):5822-31. PubMed ID: 18790802
[TBL] [Abstract][Full Text] [Related]
4. Metnase promotes restart and repair of stalled and collapsed replication forks.
De Haro LP; Wray J; Williamson EA; Durant ST; Corwin L; Gentry AC; Osheroff N; Lee SH; Hromas R; Nickoloff JA
Nucleic Acids Res; 2010 Sep; 38(17):5681-91. PubMed ID: 20457750
[TBL] [Abstract][Full Text] [Related]
5. Metnase/SETMAR: a domesticated primate transposase that enhances DNA repair, replication, and decatenation.
Shaheen M; Williamson E; Nickoloff J; Lee SH; Hromas R
Genetica; 2010 May; 138(5):559-66. PubMed ID: 20309721
[TBL] [Abstract][Full Text] [Related]
6. Neoamphimedine circumvents metnase-enhanced DNA topoisomerase IIα activity through ATP-competitive inhibition.
Ponder J; Yoo BH; Abraham AD; Li Q; Ashley AK; Amerin CL; Zhou Q; Reid BG; Reigan P; Hromas R; Nickoloff JA; LaBarbera DV
Mar Drugs; 2011; 9(11):2397-2408. PubMed ID: 22163192
[TBL] [Abstract][Full Text] [Related]
7. Geminin overexpression prevents the completion of topoisomerase IIα chromosome decatenation, leading to aneuploidy in human mammary epithelial cells.
Gardner L; Malik R; Shimizu Y; Mullins N; ElShamy WM
Breast Cancer Res; 2011 May; 13(3):R53. PubMed ID: 21595939
[TBL] [Abstract][Full Text] [Related]
8. XPO1 Inhibition using Selinexor Synergizes with Chemotherapy in Acute Myeloid Leukemia by Targeting DNA Repair and Restoring Topoisomerase IIα to the Nucleus.
Ranganathan P; Kashyap T; Yu X; Meng X; Lai TH; McNeil B; Bhatnagar B; Shacham S; Kauffman M; Dorrance AM; Blum W; Sampath D; Landesman Y; Garzon R
Clin Cancer Res; 2016 Dec; 22(24):6142-6152. PubMed ID: 27358488
[TBL] [Abstract][Full Text] [Related]
9. Selective killing of G2 decatenation checkpoint defective colon cancer cells by catalytic topoisomerase II inhibitor.
Jain CK; Roychoudhury S; Majumder HK
Biochim Biophys Acta; 2015 May; 1853(5):1195-204. PubMed ID: 25746763
[TBL] [Abstract][Full Text] [Related]
10. Cohesin removal precedes topoisomerase IIα-dependent decatenation at centromeres in male mammalian meiosis II.
Gómez R; Viera A; Berenguer I; Llano E; Pendás AM; Barbero JL; Kikuchi A; Suja JA
Chromosoma; 2014 Mar; 123(1-2):129-46. PubMed ID: 24013524
[TBL] [Abstract][Full Text] [Related]
11. Fbxo28 promotes mitotic progression and regulates topoisomerase IIα-dependent DNA decatenation.
Kratz AS; Richter KT; Schlosser YT; Schmitt M; Shumilov A; Delecluse HJ; Hoffmann I
Cell Cycle; 2016 Dec; 15(24):3419-3431. PubMed ID: 27754753
[TBL] [Abstract][Full Text] [Related]
12. Topoisomerase IIα prevents ultrafine anaphase bridges by two mechanisms.
Gemble S; Buhagiar-Labarchède G; Onclercq-Delic R; Fontaine G; Lambert S; Amor-Guéret M
Open Biol; 2020 May; 10(5):190259. PubMed ID: 32400307
[TBL] [Abstract][Full Text] [Related]
13. Roles of the C-terminal domains of topoisomerase IIα and topoisomerase IIβ in regulation of the decatenation checkpoint.
Kozuki T; Chikamori K; Surleac MD; Micluta MA; Petrescu AJ; Norris EJ; Elson P; Hoeltge GA; Grabowski DR; Porter ACG; Ganapathi RN; Ganapathi MK
Nucleic Acids Res; 2017 Jun; 45(10):5995-6010. PubMed ID: 28472494
[TBL] [Abstract][Full Text] [Related]
14. HMGB1 interacts with human topoisomerase IIalpha and stimulates its catalytic activity.
Stros M; Bacíková A; Polanská E; Stokrová J; Strauss F
Nucleic Acids Res; 2007; 35(15):5001-13. PubMed ID: 17636313
[TBL] [Abstract][Full Text] [Related]
15. Topoisomerase IIalpha controls the decatenation checkpoint.
Luo K; Yuan J; Chen J; Lou Z
Nat Cell Biol; 2009 Feb; 11(2):204-10. PubMed ID: 19098900
[TBL] [Abstract][Full Text] [Related]
16. Functional interaction of DNA topoisomerase IIalpha with the beta-catenin and T-cell factor-4 complex.
Huang L; Shitashige M; Satow R; Honda K; Ono M; Yun J; Tomida A; Tsuruo T; Hirohashi S; Yamada T
Gastroenterology; 2007 Nov; 133(5):1569-78. PubMed ID: 17983804
[TBL] [Abstract][Full Text] [Related]
17. Revised genetic requirements for the decatenation G2 checkpoint: the role of ATM.
Bower JJ; Zhou Y; Zhou T; Simpson DA; Arlander SJ; Paules RS; Cordeiro-Stone M; Kaufmann WK
Cell Cycle; 2010 Apr; 9(8):1617-28. PubMed ID: 20372057
[TBL] [Abstract][Full Text] [Related]
18. The transposase domain protein Metnase/SETMAR suppresses chromosomal translocations.
Wray J; Williamson EA; Chester S; Farrington J; Sterk R; Weinstock DM; Jasin M; Lee SH; Nickoloff JA; Hromas R
Cancer Genet Cytogenet; 2010 Jul; 200(2):184-90. PubMed ID: 20620605
[TBL] [Abstract][Full Text] [Related]
19. Topoisomerase IIalpha maintains genomic stability through decatenation G(2) checkpoint signaling.
Bower JJ; Karaca GF; Zhou Y; Simpson DA; Cordeiro-Stone M; Kaufmann WK
Oncogene; 2010 Aug; 29(34):4787-99. PubMed ID: 20562910
[TBL] [Abstract][Full Text] [Related]
20. Gambogic acid inhibits the catalytic activity of human topoisomerase IIalpha by binding to its ATPase domain.
Qin Y; Meng L; Hu C; Duan W; Zuo Z; Lin L; Zhang X; Ding J
Mol Cancer Ther; 2007 Sep; 6(9):2429-40. PubMed ID: 17876042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
